We are live on ! Find out more
BCYC

Bicycle Therapeutics

54 hedge funds and large institutions have $377M invested in Bicycle Therapeutics in 2021 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 16 increasing their positions, 13 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 3

38% more funds holding

Funds holding: 3954 (+15)

23% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 13

10% more capital invested

Capital invested by funds: $341M → $377M (+$35.7M)

2.08% more ownership

Funds ownership: 49.48%51.56% (+2.1%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
54
Holders Change
+15
Holders Change %
+38.46%
% of All Funds
0.94%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
18
Increased
16
Reduced
13
Closed
3
Calls
Puts
Net Calls
Net Calls Change

BCYC Hedge Fund Activity: Q2 2021 in Review

54 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Bicycle Therapeutics (BCYC) for Q2 2021, worth a combined $377M — up 10% from $341M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new BCYC positions and 3 closed out — a net gain of 15 holders — while 16 added to existing stakes and 13 trimmed.

The largest buyer was Eventide Asset Management, adding an estimated $22.7M. The largest seller was Atlas Venture Advisors, cutting an estimated $9.22M.

  • 54 institutional investors held Bicycle Therapeutics (BCYC) as of Q2 2021, up from 39 in Q1 2021.
  • Funds reported $377M of Bicycle Therapeutics stock for Q2 2021, up 10% quarter-over-quarter.
  • 18 funds opened new Bicycle Therapeutics positions in Q2 2021 and 3 closed out, a net change of +15 holders.
  • The largest Bicycle Therapeutics buyer in Q2 2021 was Eventide Asset Management, an estimated $22.7M added.
  • The largest Bicycle Therapeutics seller in Q2 2021 was Atlas Venture Advisors, an estimated $9.22M sold.

Based on aggregated 13F filings for Q2 2021.